APA (7th ed.) Citation

Stephenson, D., Badawy, R., Mathur, S., Tome, M., & Rochester, L. (2021). Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective. Journal of Parkinson's Disease, 11, S103. https://doi.org/10.3233/JPD-202428

Chicago Style (17th ed.) Citation

Stephenson, Diane, Reham Badawy, Soania Mathur, Maria Tome, and Lynn Rochester. "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective." Journal of Parkinson's Disease 11 (2021): S103. https://doi.org/10.3233/JPD-202428.

MLA (9th ed.) Citation

Stephenson, Diane, et al. "Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective." Journal of Parkinson's Disease, vol. 11, 2021, p. S103, https://doi.org/10.3233/JPD-202428.